Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million

Stock Information for Lifecore Biomedical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lifecore Biomedical Inc.

Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences
Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference
Lifecore Biomedical Announces Special Stockholder Meeting
Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference
Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.